Detection of the Arg702Trp, Gly908Arg and Leu1007fsinsC polymorphisms of the NOD2/CARD15 gene by real-time PCR with melting curve analysis
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 378892312 | ||
| 003 | CHVBK | ||
| 005 | 20180305123457.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 161128e20040510xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1515/CCLM.2004.084 |2 doi |
| 035 | |a (NATIONALLICENCE)gruyter-10.1515/CCLM.2004.084 | ||
| 245 | 0 | 0 | |a Detection of the Arg702Trp, Gly908Arg and Leu1007fsinsC polymorphisms of the NOD2/CARD15 gene by real-time PCR with melting curve analysis |h [Elektronische Daten] |c [Christian Rüegg, Martin Hersberger, Barbara Wusk, Katharina Rentsch, Gerd A. Kullak-Ublick, Arnold von Eckardstein, Friedrich E. Maly] |
| 520 | 3 | |a Crohn's disease is a complex disorder, with multiple genetic traits. A frameshift mutation (Leu1007fsinsC) and two missense mutations (Gly908Arg and Arg702Trp) in the NOD2/CARD15 gene are strongly associated with susceptibility to Crohn's disease. The presence of one of these risk alleles confers a 2- to 4-fold increase in the risk of developing Crohn's disease, and the presence of two mutant alleles increases the risk over 20-fold. To facilitate the analysis of these polymorphisms, we developed three LightCycler assays to detect the missense mutations Arg702Trp and Gly908Arg and the frameshift mutation Leu100fsinsC in the NOD2/CARD15 gene. All three assays can be run simultaneously on one LightCycler using identical cycling parameters. Analysis of 53 DNAs from Crohn's patients helped to identify carriers at allele frequencies similar to other Caucasian populations. The sequencing of such DNAs confirmed the accuracy of the assays. In conclusion, we present three rapid and robust assays to detect the Arg702Trp, the Gly908Arg and the Leu100fsinsC mutations in the NOD2/CARD15 gene. | |
| 540 | |a Copyright © 2004 by Walter de Gruyter GmbH & Co. KG | ||
| 690 | 7 | |a Medical equipment & techniques |2 nationallicence | |
| 690 | 7 | |a Medical diagnosis |2 nationallicence | |
| 690 | 7 | |a Diseases & disorders |2 nationallicence | |
| 700 | 1 | |a Rüegg |D Christian |4 aut | |
| 700 | 1 | |a Hersberger |D Martin |4 aut | |
| 700 | 1 | |a Wusk |D Barbara |4 aut | |
| 700 | 1 | |a Rentsch |D Katharina |4 aut | |
| 700 | 1 | |a Kullak-Ublick |D Gerd A. |4 aut | |
| 700 | 1 | |a Eckardstein |D Arnold von |4 aut | |
| 700 | 1 | |a Maly |D Friedrich E. |4 aut | |
| 773 | 0 | |t Clinical Chemistry and Laboratory Medicine |d Walter de Gruyter |g 42/5(2004-05-10), 494-498 |x 1434-6621 |q 42:5<494 |1 2004 |2 42 |o cclm | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/CCLM.2004.084 |q text/html |z Onlinezugriff via DOI |
| 908 | |D 1 |a research article |2 jats | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1515/CCLM.2004.084 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Rüegg |D Christian |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Hersberger |D Martin |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Wusk |D Barbara |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Rentsch |D Katharina |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kullak-Ublick |D Gerd A. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Eckardstein |D Arnold von |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Maly |D Friedrich E. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Clinical Chemistry and Laboratory Medicine |d Walter de Gruyter |g 42/5(2004-05-10), 494-498 |x 1434-6621 |q 42:5<494 |1 2004 |2 42 |o cclm | ||
| 900 | 7 | |b CC0 |u http://creativecommons.org/publicdomain/zero/1.0 |2 nationallicence | |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-gruyter | ||